metformin has been researched along with Neurilemoma in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"Aspirin has also been associated with decreased VS growth in animal studies." | 1.91 | Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model. ( Burns, A; Hartman, Y; Hunter, JB; Killeen, DE; Lora Gonzalez, MA; Manickavel, S; Walsh, E; Warram, J, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Manickavel, S | 1 |
Hartman, Y | 1 |
Burns, A | 1 |
Lora Gonzalez, MA | 1 |
Warram, J | 1 |
Walsh, E | 1 |
Hunter, JB | 1 |
Killeen, DE | 1 |
1 other study available for metformin and Neurilemoma
Article | Year |
---|---|
Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model.
Topics: Animals; Aspirin; Metformin; Mice; Mice, Nude; Neurilemmoma; Neuroma, Acoustic; Rats | 2023 |